Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Acquisitions

    Boston Scientific; Boston Scientific Santa Rosa; TriVascular; TV2 Holding; Diomed Holdings; AngioDynamics; Vascular Solutions; MedCath; Southwest Arizona Heart and Vascular Center; Yuma Regional Medical Center; Heart, Lung and Vascular Center of Yuma; Medrad; Bayer HealthCare; Possis Medical; Pediatrix Medical Group; Children's Heart Center; ProMetic Life Sciences; American Red Cross; Pathogen Removal and Diagnostic Technologies
  • International report

    A novel mobile gamma camera unit designed to bring widely used scintigraphic tomography (SPECT) out of advanced radiology suites and into the emergency room and intensive care units for seriously ill patients has taken the first steps to advance beyond Sweden and enter new markets in Germany and India.
  • FDA draft guidance poised to raise bar higher for DES

    After more than two years of questions raised by clinical data concerning the safety and efficacy of drug-eluting stents (DES), declines in the sales of DES devices because of these questions, and DES developers looking for R&D and regulatory guidance, FDA last month issued a new set of guidelines, in draft form, concerning the development, testing and manufacture of DES devices.
  • REVERSE data still likely to boost ICD market prospects

    The implantable cardiac defibrillator (ICD) market may be poised to rebound from the black eye it has suffered following recalls and recent lead malfunctions, based on news from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) trial - intended to establish that patients with mild heart failure may benefit from cardiac resynchronization therapy (CRT).
  • The CD&D Interview: Charles Maroney

    Charles Maroney has been president/CEO, since February 2006, of CardioMind (Sunnyvale, California), a development-stage company focused on a small-diameter stent delivery platform with applications in treating coronary, neuro and peripheral artery disease. This is currently a $5 billion-plus worldwide market.
  • Use of Cardica's C-Port offers big CABG savings

    Results from a six-month economic analysis comparing the cost of off-pump, "beating heart" coronary artery bypass graft (CABG) procedures with the cost of traditional on-pump CABG surgery showed that beating-heart CABG saved $1,684 per procedure compared to traditional bypass surgery.
  • Agreements

    eResearchTechnology; nSpire Health, Advanced Cell Technology; Chandler Regional Medical Center; Mercy Gilbert Medical Center; Catholic Healthcare West; Alliant Healthcare Products; Premier Purchasing Partners; Angiotech Pharmaceuticals; Rex Medical; Cardiac Science; Misys Healthcare; Cardinal Health; GE Healthcare; Global Research Services; CardioDynamics; Piedmont Heart Institute; Cardiology of Georgia; Piedmont Healthcare
  • Full May 2008 Issue in PDF

  • Clinical Briefs in Primary Care supplement

  • Updates by Carol A. Kemper, MD, FACP

    Trauma in wartime is especially high risk given the nature of the injuries, the high risk of infection, and the limited access to optimal medical care.